Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Bangladesh
  4. Dhaka Stock Exchange
  5. Orion Pharma Limited
  6. News
  7. Summary
    ORIONPHARM   BD0486OPL004

ORION PHARMA LIMITED

(ORIONPHARM)
  Report
SummaryChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Orion Pharma Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020

02/01/2021 | 03:07pm EDT

Orion Pharma Limited announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced sales was BDT 2,394.716 million compared to BDT 1,537.001 million a year ago. Operating income was BDT 352.762 million compared to BDT 279.197 million a year ago. Net income was BDT 282.899 million compared to BDT 226.953 million a year ago. Basic earnings per share from continuing operations was BDT 1.21 compared to BDT 0.97 a year ago. For the half year, sales was BDT 5,323.719 million compared to BDT 3,763.556 million a year ago. Operating income was BDT 596.251 million compared to BDT 601.735 million a year ago. Net income was BDT 473.992 million compared to BDT 500.401 million a year ago. Basic earnings per share from continuing operations was BDT 2.03 compared to BDT 2.14 a year ago.


ę S&P Capital IQ 2021
All news about ORION PHARMA LIMITED
02/01Orion Pharma Limited Reports Earnings Results for the Second Quarter Ended De..
CI
2020Orion Pharma Limited Recommends Cash Divided for the Year Ended on June 30, 2..
CI
2020Tenax Therapeutics Gains North American Rights to Oral Levosimendan through E..
AQ
2020Orion Pharma Limited Reports Earnings Results for the Third Quarter Ended Mar..
CI
2020Orion Pharma Limited Appoints Zareen Karim as Managing Director
CI
2019Orion Pharma Limited Reports Earnings Results for the First Quarter Ended Sep..
CI
2019Orion Pharma Limited Recommends Cash Dividend for the Year Ended on June 30, ..
CI
2019Orion Pharma Limited Reports Earnings Results for the Third Quarter Ended Mar..
CI
2019Orion Pharma Limited Reports Earnings Results for the Second Quarter Ended De..
CI
2018Orion Pharma Limited Reports Earnings Results for the First Quarter Ended Sep..
CI
More news
Financials
Sales 2020 7 648 M 90,1 M 90,1 M
Net income 2020 666 M 7,84 M 7,84 M
Net Debt 2020 12 647 M 149 M 149 M
P/E ratio 2020 14,8x
Yield 2020 2,38%
Capitalization 16 146 M 190 M 190 M
EV / Sales 2019 1,88x
EV / Sales 2020 2,94x
Nbr of Employees 2 688
Free-Float 100%
Chart ORION PHARMA LIMITED
Duration : Period :
Orion Pharma Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Salman Obaidul Karim Chief Executive Officer, Executive Director & MD
Samaresh Banik CFO, Senior VP & Head-Finance & Accounts
Mohammad Obaidul Karim Chairman
Mohammad Ibrahim Khalil Head-Internal Audit & Compliance
Mohammad Forhad Hossain Administration Manager
Sector and Competitors
1st jan.Capi. (M$)
ORION PHARMA LIMITED26.14%190
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604